Our projects

Find out about our current work

We support projects at different stages of the innovation pathway to deliver positive health impact. These are some of the key programmes of work and innovations we are currently supporting. Please get in touch to find out more. We continue to add more projects so do check back regularly.

PROJECT DESCRIPTION

EarlyCDT Lung

EarlyCDT Lung is a test for the levels of seven autoantibodies to tumour-associated antigens to help improve the detection of lung cancer.

It was created by Oncimmune and Eastern AHSN is looking at supporting a project in primary care across parts of the region.  

Cytosponge

Cytosponge is a tool to detect Barrett’s Oesophagus – a precursor to oesophagael cancer – which is minimally invasive and can be used in primary care. Using Cytosponge a patient swallows a capsule, about the size of a multi-vitamin pill, which is attached to a cord. When swallowed, the capsule dissolves to release a sponge. The sponge can then be removed by a nurse a few minutes later collecting cells along its passage. These cells are then tested in the laboratory using an accurate method developed by the Fitzgerald Laboratory.

Eastern AHSN is looking at how to support the use of Cytosponge in primary care across the region. 

Active+me

Active+ helps increase the confidence of people with long term conditions to monitor and manage their health using wearable technology. Eastern AHSN has supported the roll out of the programme in our region and commissioned an evaluation of the service.

Medic Bleep

Medic Bleep enables hospital and community staff to communicate and collaborate within and across organisations, sharing vital information about patients accurately and safely whilst also save time.
Eastern AHSN supported the evaluation of both a pilot and wider roll out across West Suffolk NHS Foundation Trust.

The COVID Oximetry at Home Programme (virtual ward)

COVID Oximetry at Home is an enhanced package of care using pulse oximetry to detect early deterioration of individuals with confirmed or suspected COVID-19.

Gut reaction

Eastern AHSN is a key partner in Gut Reaction, the Health Data Research Hub for inflammatory bowel disease (IBD) supported by HDRUK which is led by the NIHR BioResource. The hub will integrate data from multiple sources and create a secure research resource that allows approved researchers to access data, whilst protecting the privacy of individuals.

Skin Analytics

Skin Analytics has developed an app combined with a dermascopic attachment, which uses artificial intelligence (AI) to analyse images of skin to help monitor moles and automatically filter urgent cases which are flagged to primary care as needing expert review and potentially a referral to a dermatologist. 

PINCER

PINCER is a pharmacist-led IT intervention shown to reduce clinically important errors in general practice prescribing by up to 50%.  It uses software to search GP practice computer systems to identify at-risk patients who are being prescribed drugs commonly associated with medication errors so that actions can be taken to reduce the risk. 

This is a national AHSN Network adoption and spread initiative. 

Serenity Integrated Mentoring (SIM)

Eastern AHSN is supporting the rollout of Serenity Integrated Mentoring (SIM) – providing a personalised package of clinical care and boundary setting for people in crisis, developed with specially selected and trained police officers and community mental health teams.

ESCAPE-pain

ESCAPE-pain classes help people with osteoarthritis manage their condition better and have less pain thanks to an innovative six-week physiotherapist led group exercise and education rehabilitation programme.
This is a national AHSN Network adoption and spread initiative.

Electronic Medicines Optimisation Pathway (EMOP)

Electronic Medicines Optimisation Pathway (EMOP) is reducing medication errors when patients are discharged from hospital by providing community pharmacists with updated medication information.
The tool, also referred to as transfers of care around medicines (TCAM), is a national AHSN Network adoption and spread initiative.

Improving diagnosis of eating disorders

Supporting mental health teams to speed up diagnosis and treatment of eating disorders in young people.

This is a national AHSN Network adoption and spread initiative. 

National cardiovascular disease (CVD) prevention programme

Improving the detection and management of the high-risk conditions – Atrial Fibrillation (AF), high blood pressure and high cholesterol as well as early diagnosis of Familial Hypercholesterolaemia (FH). 

Endoscope-i

Endoscope-i allows the acquisition of high definition images of the ear, nose and throat (ENT). The system combines the e-i Pro camera app with a bespoke engineered endoscope-i adaptor which fits securely onto an iPhone. This enables a quick diagnostic process and reduced hospital visits.
Eastern AHSN is exploring the development of Endoscope-I in the region, including introducing it to partner organisations with a view to establishing pilots in the region.

Placental growth factor (PlGF) based testing

PlGF-based testing can help with clinical risk stratification for women with suspected pre-eclampsia, meaning they can be treated appropriately according to their need, improving both patient experience and outcomes. 

High-sensitivity troponin testing

Assisting the earlier diagnosis of heart attacks to ensure access to appropriate treatment and avoid unnecessary hospital admissions via a high-sensitivity troponin test that enables healthcare professionals to rule out cardiac arrest within four hours, if the test results are available within three hours of presentation.  

Share your idea

Do you have a great idea that could make a positive health impact?

Get involved

Newsletter